Medsien.

I. Who They Are NowQuiet, useful, billable.

Medsien is what happens when you take Medicare's alphabet soup - CCM, RPM, RTM, PCM, APCM, TCM, AWV - and ask, with a straight face, why nobody has ever bothered to put it in one place. The San Francisco company sells a platform called Nura and a team of certified care partners who actually staff it. Clinics get one vendor, one workflow and one audit trail. Patients get someone on the other end of the line who knows their name. CMS, in theory, gets fewer hospital readmissions.

The pitch is not flashy. The pitch is also not optional. Some 150 million Americans live with a chronic condition. The average independent clinic has neither the bandwidth nor the back-office to bill for managing them between appointments - and the codes that allow it are now a decade old, layered like sediment. Medsien is the company quietly clearing the layer.

II. The Problem They SawA market that pays for prevention - if you can find it.

The American healthcare system is, famously, optimised for the visit. You show up, you get billed, everyone is satisfied. The 364 days between visits are nobody's job, which is exactly why so many of them end in the emergency room. Medicare has tried to fix this with care-management codes - reimbursement for the unglamorous work of staying in touch with patients - but the codes carry rules. Twenty minutes per month here. A device reading there. Logged time, recorded consent, written notes. Miss a step, lose the claim.

For most clinics this is a part-time job they cannot afford to hire for. So they don't. The codes go unused. The patients go unmanaged. The hospital admissions roll in on schedule.

III. The Founders' BetHire the humans. Then build the software.

Hamed Ahmadi and Sina Torabi met in Seattle in 2018. The story does not involve a garage, which is refreshing. It involves two engineers who had spent enough time near American healthcare to understand that "AI-only" would not work and "people-only" would not scale. They picked both. Ahmadi runs the company as CEO. Torabi co-founded it. The team they built is now 110-strong, fully remote, split between the United States and Türkiye - a structure that looks counterintuitive on paper and obvious once you remember that remote care, by definition, does not require an office.

Their bet is contrarian in a particular way. Most healthtech founders pitch software that will replace clinical labor. Medsien's founders pitched software that would make clinical labor cheaper to hire and easier to bill for. Less moonshot. More plumbing.

IV. The ProductOne platform, several acronyms, a person on the line.

The product is called Nura. It does the boring parts of remote care management at scale: identifies eligible patients in the EHR, dispatches outreach, tracks minutes, records calls, surfaces alerts, exports billing-ready claims. Generative AI sits underneath the workflow rather than on top of it - drafting summaries, flagging escalations, doing the patient-facing typing nobody wants to do. The care partners do the talking.

Above: the alphabet, decoded. Each one a billing code. Each one a workflow Medsien runs end-to-end.

V. The ProofWhat the numbers say.

The pitch deck version of Medsien is straightforward: the platform scales from a hundred patients to a hundred thousand without re-architecting, the audit trail is built to survive a CMS audit, and the bill-back is fast enough that clinics see revenue inside a single quarter. The independent version is more interesting. Family practices report patient compliance climbing without adding clinical staff. FQHCs - federally qualified health centers serving the underinsured - can finally stand up chronic care programs that pay for themselves.

VI. The MissionA boring sentence, said carefully.

The company's stated mission - "the leading provider of scalable remote care management" - is the kind of sentence that wins zero design awards and exactly the right kind of customer. Medsien is not trying to reinvent the doctor's visit. It is trying to make the 364 days between visits billable, traceable and humane. There is a version of the same idea that sells you an app and a fitness band. Medsien is selling a hospital the staff and the software to do this for ten thousand of its highest-risk patients at once.

The unglamorous corollary: Medsien is, in essence, betting on regulation. The CCM codes only matter because CMS pays them. The RTM codes only matter because Medicare expanded them. RPM is currently under regulatory scrutiny, which Medsien talks about openly - the company's response is to lean into the audit trail rather than around it. Transparency, in their telling, is the moat.

VII. Why It Matters TomorrowThe boring infrastructure of staying alive.

Healthcare loves the future tense. Cures, breakthroughs, moonshots. The boring truth is that most of the next decade's healthcare cost savings will come from the unglamorous work of keeping chronic patients out of the hospital, and that work is largely a software problem with a labor component attached. Medsien is one of the small handful of companies building both halves at the same time. If you believe Medicare will keep paying for prevention, the company has a long runway. If you believe American clinics will keep being short-staffed, the runway is longer still.

The competition - Cadence, CareSimple, Optimize.health, HealthSnap, 100Plus, a long tail of point solutions - is mostly trying to win on hardware or on AI. Medsien is trying to win on the part nobody else wants: payroll, compliance and CPT code 99490. Less alluring. More durable.